ArticleFrontiers in oncology2023

Case report: Complete and durable response to larotrectinib (TRK inhibitor) in an infant diagnosed with angiosarcoma harbouring a

Catherine Cervi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.